AbbVie’s Qulipta gains edge on Pfizer’s Nurtec with FDA approval to prevent chronic migraines
AbbVie’s Qulipta has gained an edge in the heated migraine market thanks to a new approval to prevent chronic migraines.
The new FDA nod makes the pill the only o...


















